{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:54:56Z","timestamp":1762865696222,"version":"3.44.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"13-14","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.clinbiochem.2010.06.016","type":"journal-article","created":{"date-parts":[[2010,7,2]],"date-time":"2010-07-02T04:23:38Z","timestamp":1278044618000},"page":"1074-1078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effect of valproic acid treatment on copper availability in adult epileptic patients"],"prefix":"10.1016","volume":"43","author":[{"given":"Natalia","family":"Lamp\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Carlos","family":"Tutor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0005","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1016\/j.peptides.2006.07.014","article-title":"Valproate and copper accelerate TRH-like peptide synthesis in male rat pancreas and reproductive tissues","volume":"27","author":"Pekary","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0010","doi-asserted-by":"crossref","first-page":"851S","DOI":"10.1093\/ajcn\/88.3.851S","article-title":"Liver as key organ in the supply, storage, and excretion of copper","volume":"88","author":"Roberts","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0015","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/hep.1840010411","article-title":"Choleretic effect of valproic acid in the rat","volume":"1","author":"Watkins","year":"1981","journal-title":"Hepatology"},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0020","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0920-1211(02)00155-9","article-title":"Valproic acid increases biliary copper excretion in the rat","volume":"51","author":"Kuzuya","year":"2002","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0025","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1528-1157.1992.tb01709.x","article-title":"Serum copper and zinc levels in epileptic children with valproate treatment","volume":"33","author":"Kaji","year":"1992","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0920-1211(01)00322-9","article-title":"Serum copper, zinc selenium, glutathione peroxidase, and superoxide dismutase levels in epileptic children before and after 1year of sodium valproate and carbamazepine therapy","volume":"48","author":"Verrotti","year":"2002","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0035","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1528-1157.1995.tb02574.x","article-title":"Plasma trace element, plasma glutathione peroxidise, and superoxide dismutase levels in epileptic children receiving antiepileptic drug therapy","volume":"36","author":"Kurecki","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0040","first-page":"61","article-title":"Effect of antiepileptic drug on serum zinc and copper concentrations in epileptic patients","volume":"31","author":"Kuzuya","year":"1993","journal-title":"Int. J. Clin. Pharmacol."},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0045","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1600-0676.1988.tb01008.x","article-title":"Hypoceruloplasminemia and ultrastructural changes resembling Wilson' s disease in non-alcoholic liver steatosis. A clinical and pathological study of five cases","volume":"8","author":"Geubel","year":"1988","journal-title":"Liver"},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0050","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S1542-3565(05)00181-3","article-title":"Diagnostic value of quantitative hepatic copper determination in patients with Wilson's disease","volume":"3","author":"Ferenci","year":"2005","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0055","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1053\/j.gastro.2008.04.007","article-title":"Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease","volume":"135","author":"Aigner","year":"2008","journal-title":"Gastroenterol"},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0060","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/ana.20074","article-title":"Valproate therapy and non-alcoholic fatty liver disease","volume":"55","author":"Luef","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0065","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.eplepsyres.2009.04.004","article-title":"Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment","volume":"86","author":"Luef","year":"2009","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0070","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.eplepsyres.2003.08.008","article-title":"Assessment of copper status in epileptic patients treated with anticonvulsant drugs by measuring the specific oxidase activity of ceruloplasmin","volume":"56","author":"Tutor-Crespo","year":"2003","journal-title":"Epilepsy Res."},{"issue":"Suppl 3","key":"10.1016\/j.clinbiochem.2010.06.016_bb0075","doi-asserted-by":"crossref","first-page":"948S","DOI":"10.1093\/jn\/133.3.948S","article-title":"Biomarkers of trace mineral intake and status","volume":"133","author":"Hambidge","year":"2003","journal-title":"J. Nutr."},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0080","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/clinchem\/40.8.1479","article-title":"Assessment of copper nutritional status","volume":"40","author":"Milne","year":"1994","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0085","doi-asserted-by":"crossref","first-page":"1041S","DOI":"10.1093\/ajcn\/67.5.1041S","article-title":"Copper intake and assessment of copper status","volume":"Suppl 67","author":"Milne","year":"1998","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0090","first-page":"46","article-title":"Assessment of copper status in pregnant women","volume":"8","author":"Louro","year":"2003","journal-title":"Eastern J Med"},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0095","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1258\/000456303763046021","article-title":"Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically","volume":"40","author":"Walshe","year":"2003","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0009-8981(01)00607-6","article-title":"Assessment of copper status in pregnancy by means of determining the specific oxidase activity of ceruloplasmin","volume":"312","author":"Louro","year":"2001","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0105","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/clinchem\/39.5.883","article-title":"Assessment of copper status: effect of age and gender on reference ranges in healthy adults","volume":"39","author":"Milne","year":"1993","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0110","series-title":"Tietz Fundamentals of Clinical Chemistry","first-page":"568","article-title":"Trace elements","author":"Milne","year":"2001"},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0115","first-page":"53","article-title":"Use of serum copper to caeruloplasmin ratio to highlight relative copper excess in Wilson's disease","volume":"43","author":"Beetham","year":"2006","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0120","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/jcp.2006.041756","article-title":"Copper: ceruloplasmin ratio","volume":"60","author":"Twomey","year":"2007","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0125","first-page":"119","article-title":"Determinaci\u00f3n de la actividad oxid\u00e1sica de la ceruloplasmina en los analizadores Cobas Bio y Cobas Fara","volume":"25","author":"Louro","year":"1991","journal-title":"Acta Bioquim. Clin. Latinoam."},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0130","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1254\/jphs.FPE04007X","article-title":"A theoretical method for normalizing total serum valproic acid concentration in hypoalbuminemic patients","volume":"97","author":"Hermida","year":"2005","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0135","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/clinchem\/28.6.1367","article-title":"Serum copper concentration and hepatic enzyme induction during long-term therapy with anticonvulsants","volume":"28","author":"Tutor","year":"1982","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0140","unstructured":"AHA\/CDC scientific statement on markers of inflammation and cardiovascular disease. Circulation 2003; 107: 499-511."},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0145","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ana.21615","article-title":"Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein","volume":"65","author":"Mintzer","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0150","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/j.1528-1167.2009.02024.x","article-title":"Long-term antiepileptic drug therapy contributes to the acceleration of atherosclerosis","volume":"50","author":"Tan","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0155","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.nutr.22.012502.114457","article-title":"Ceruloplasmin metabolism and function","volume":"22","author":"Hellman","year":"2002","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0160","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.lab.2004.08.005","article-title":"Value of an enzymatic assay for the determination of serum ceruloplasmin","volume":"144","author":"Macintyre","year":"2004","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0165","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1586\/ern.09.27","article-title":"Copper in Alzheimer's disease: too much or to little?","volume":"9","author":"Quinn","year":"2009","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.brainresbull.2009.09.003","article-title":"Valproic acid as a promising agent to combat Alzheimer's disease","volume":"81","author":"Zhang","year":"2010","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0175","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.brainres.2008.10.056","article-title":"Copper transport to the brain by the blood\u2013brain barrier and blood-CSF barrier","volume":"1248","author":"Choi","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.clinbiochem.2010.06.016_bb0180","first-page":"431","article-title":"Plasma copper and ceruloplasmin in patients with alcoholic liver steatosis","volume":"109","author":"Uhlikova","year":"2008","journal-title":"Bratisl. Lek. Listy"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912010003048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912010003048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:33:12Z","timestamp":1757863992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912010003048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":36,"journal-issue":{"issue":"13-14","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0009912010003048"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2010.06.016","relation":{},"ISSN":["0009-9120"],"issn-type":[{"type":"print","value":"0009-9120"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of valproic acid treatment on copper availability in adult epileptic patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2010.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}